Evolent Health, Inc. — Director's Dealing 2021

Aug 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Evolent Health, Inc. (EVH)
CIK: 0001628908
Period of Report: 2021-08-02

Reporting Person: Tutewohl Steve (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-02	Class A Common Stock	M	3331	$13.95	Acquired	117434	Direct
2021-08-02	Class A Common Stock	S	3331	$23.02	Disposed	114103	Direct
2021-08-02	Class A Common Stock	M	2625	$18.25	Acquired	116728	Direct
2021-08-02	Class A Common Stock	S	2625	$23.02	Disposed	114103	Direct
2021-08-03	Class A Common Stock	M	11229	$18.25	Acquired	125332	Direct
2021-08-03	Class A Common Stock	S	11229	$23.02	Disposed	114103	Direct
2021-08-03	Class A Common Stock	M	13801	$13.95	Acquired	127904	Direct
2021-08-03	Class A Common Stock	S	13801	$23.02	Disposed	114103	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-02	Class A Common Stock Option (right to buy)	$13.95	M	3331	Disposed	2028-02-01	Class A Common Stock (3331.0)	Direct
2021-08-02	Class A Common Stock Option (right to buy)	$18.25	M	2625	Disposed	2027-02-01	Class A Common Stock (2625.0)	Direct
2021-08-03	Class A Common Stock Option (right to buy)	$13.95	M	13801	Disposed	2028-02-01	Class A Common Stock (13801.0)	Direct
2021-08-03	Class A Common Stock Option (right to buy)	$18.25	M	11229	Disposed	2027-02-01	Class A Common Stock (11229.0)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2021.

F2: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.13, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.99 to $23.13, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 22.99 to $23.14, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.14, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The Class A Common Stock Options exercised vested on February 1, 2019.

F8: The Class A Common Stock Options exercised vested on February 1, 2018 and February 1, 2019.

F9: The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020 and February 1, 2021.